ALKERMES | L'Utile Operativo



Operating Profit Cambiamento Data
AbbVie USD 3.73B 5.22B 2025-03
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
ALKERMES USD 13.79M 148.9M 2025-03
Amgen USD 1.29B 1.02B 2025-03
Biogen USD 311.2M 130.2M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
J&J USD 13.63B 9.74B 2025-03
Malin Corporation EUR -700000 1.6M 2024-06
Merck USD 5.87B 1.57B 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Otsuka Holdings JPY 124.42B 61.9B 2025-03
Pfizer USD 3.67B 4.08B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



ALKERMES L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.